Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus

BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon-γ Production in Autoimmunity

(2015) Christine M. Coquery et al.   Arthritis & Rheumatology

Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients

(2014) Ghada Boghdadi et al.   RHEUMATOLOGY INTERNATIONAL

Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis

(2013) Qingyu Cheng et al.   ANNALS OF THE RHEUMATIC DISEASES

The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity

(2013) Fabien B. Vincent et al.   CYTOKINE & GROWTH FACTOR REVIEWS

BAFF and TACI Gene Expression Are Increased in Patients with Untreated Very Early Rheumatoid Arthritis

(2013) R. A. Moura et al.   JOURNAL OF RHEUMATOLOGY

Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF

(2013) E. Y. Abu-Rish et al.   RHEUMATOLOGY

APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis

(2012) Worapot Treamtrakanpon et al.   ARTHRITIS RESEARCH & THERAPY

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation

(2011) Jinoh Kim et al.   AUTOIMMUNITY

B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus

(2011) C. Jiang et al.   JOURNAL OF IMMUNOLOGY

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Belimumab

(2011) Iñaki Sanz et al.   NATURE REVIEWS DRUG DISCOVERY

Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices

(2010) M. Hegazy et al.   CLINICAL IMMUNOLOGY

Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients

(2010) LD Zhao et al.   LUPUS

The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88

(2010) Bing He et al.   NATURE IMMUNOLOGY

Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity

(2008) S Candon et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

(2008) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95

(2008) Annett M. Jacobi et al.   ARTHRITIS AND RHEUMATISM

Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus

(2008) A Hostmann et al.   LUPUS

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms

(2008) Annie George-Chandy et al.   ARTHRITIS RESEARCH & THERAPY